Limited coverage drugs – deferiprone
Special Authority requests can now be submitted online. It's simple and quick!
Learn more or log in.
|
Generic name |
deferiprone |
|---|---|
|
Strength |
100 mg/mL, 1000 mg |
|
Form |
oral solution, tablet |
|
Special Authority criteria |
Approval period |
|---|---|
|
Treatment of transfusion-dependent iron overload due to thalassemia syndromes, where iron chelation therapy is required, according to established criteria*, and when prescribed by a hematologist. |
Initial request: 1 year Renewal request: 1 year |
Practitioner exemptions
- None
Special notes
- None
Special Authority request form(s)
* Click on the Special Authority Form below for full criteria:
